Acute reversible hypoxemia in systemic lupus erythematosus: a new syndrome or an index of disease activity?
Identifieur interne : 002B86 ( Main/Exploration ); précédent : 002B85; suivant : 002B87Acute reversible hypoxemia in systemic lupus erythematosus: a new syndrome or an index of disease activity?
Auteurs : V. M. Martinez-Taboada [Espagne] ; R. Blanco [Espagne] ; J. Armona [Espagne] ; J. L. Fernandez-Sueiro [Espagne] ; V. Rodriguez-Valverde [Espagne]Source :
- Lupus [ 0961-2033 ] ; 1995-08.
English descriptors
- Teeft :
- Abramson, Acute lupus pneumonitis, Aggregation, Arthritis, Arthritis rheum, Chest radiograph, Clinical features, Complement split product, Complement split products, Complete resolution, Corticosteroid, Corticosteroid therapy, Disease activity, Distress syndrome, Endothelial cells, Erythematosus, First patient, Granulocyte aggregation, High doses, Homogeneous pattern, Hypoxemia, Hypoxia, Independent syndrome, Laboratory data, Leukocyte aggregation, Lower extremities, Lupus, Malar rash, Moderate dyspnea, Multiple blood, Obvious parenchymal lung disease, Other hand, Physical examination, Pleuritic chest pain, Pulmonary hemorrhage, Pulmonary manifestations, Radiograph, Respiratory symptoms, Serum creatinine, Serum levels, Several joints, Syndrome, Systemic, Systemic activity, Systemic lupus erythematosus, Weight loss, White woman.
Abstract
In 1991, Abramson et al reported a new syndrome of acute reversible hypoxemia (ARH) in patients with severe SLE (systemic lupus erythematosus). This syndrome was characterized by an unexplained abnormal value of arterial blood gases (ABG) without obvious parenchymal lung disease, and a good response to high-dose corticosteroid therapy. After we became aware of this entity, four of 16 patients admitted to our unit because of a SLE flare presented respiratory symptoms and abnormal ABG consistent with ARH. In none of our patients were the pulmonary manifestations a prominent clinical feature of the disease. Furthermore, in two of them, treatment with high-dose aspirin and moderate to low doses of corticosteroids was sufficient to improve the pulmonary manifestations, but not to control the systemic activity of the disease. Therefore, we believe that this new pulmonary finding more than a clinically independent syndrome represents an index of disease activity in patients with SLE.
Url:
DOI: 10.1177/096120339500400405
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002534
- to stream Istex, to step Curation: 002534
- to stream Istex, to step Checkpoint: 001977
- to stream Main, to step Merge: 002C44
- to stream Main, to step Curation: 002B86
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Acute reversible hypoxemia in systemic lupus erythematosus: a new syndrome or an index of disease activity?</title><author wicri:is="90%"><name sortKey="Martinez Taboada, V M" sort="Martinez Taboada, V M" uniqKey="Martinez Taboada V" first="V. M." last="Martinez-Taboada">V. M. Martinez-Taboada</name></author><author wicri:is="90%"><name sortKey="Blanco, R" sort="Blanco, R" uniqKey="Blanco R" first="R." last="Blanco">R. Blanco</name></author><author wicri:is="90%"><name sortKey="Armona, J" sort="Armona, J" uniqKey="Armona J" first="J." last="Armona">J. Armona</name></author><author wicri:is="90%"><name sortKey="Fernandez Sueiro, J L" sort="Fernandez Sueiro, J L" uniqKey="Fernandez Sueiro J" first="J. L." last="Fernandez-Sueiro">J. L. Fernandez-Sueiro</name></author><author wicri:is="90%"><name sortKey="Rodriguez Valverde, V" sort="Rodriguez Valverde, V" uniqKey="Rodriguez Valverde V" first="V." last="Rodriguez-Valverde">V. Rodriguez-Valverde</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A35BEBC4904D4EF59DB4F43F3B4B034EE4F5FD8A</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1177/096120339500400405</idno><idno type="url">https://api.istex.fr/ark:/67375/M70-0V3PBK36-9/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002534</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002534</idno><idno type="wicri:Area/Istex/Curation">002534</idno><idno type="wicri:Area/Istex/Checkpoint">001977</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001977</idno><idno type="wicri:doubleKey">0961-2033:1995:Martinez Taboada V:acute:reversible:hypoxemia</idno><idno type="wicri:Area/Main/Merge">002C44</idno><idno type="wicri:Area/Main/Curation">002B86</idno><idno type="wicri:Area/Main/Exploration">002B86</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Acute reversible hypoxemia in systemic lupus erythematosus: a new syndrome or an index of disease activity?</title><author wicri:is="90%"><name sortKey="Martinez Taboada, V M" sort="Martinez Taboada, V M" uniqKey="Martinez Taboada V" first="V. M." last="Martinez-Taboada">V. M. Martinez-Taboada</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Rheumatology Division, Hospital Universitario "M.Valdecilla', Facultad de Medicina, Universidad de Cantabria, Santander</wicri:regionArea><wicri:noRegion>Santander</wicri:noRegion></affiliation></author><author wicri:is="90%"><name sortKey="Blanco, R" sort="Blanco, R" uniqKey="Blanco R" first="R." last="Blanco">R. Blanco</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Rheumatology Division, Hospital Universitario "M.Valdecilla', Facultad de Medicina, Universidad de Cantabria, Santander</wicri:regionArea><wicri:noRegion>Santander</wicri:noRegion></affiliation></author><author wicri:is="90%"><name sortKey="Armona, J" sort="Armona, J" uniqKey="Armona J" first="J." last="Armona">J. Armona</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Rheumatology Division, Hospital Universitario "M.Valdecilla', Facultad de Medicina, Universidad de Cantabria, Santander</wicri:regionArea><wicri:noRegion>Santander</wicri:noRegion></affiliation></author><author wicri:is="90%"><name sortKey="Fernandez Sueiro, J L" sort="Fernandez Sueiro, J L" uniqKey="Fernandez Sueiro J" first="J. L." last="Fernandez-Sueiro">J. L. Fernandez-Sueiro</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Rheumatology Division, Hospital Universitario "M.Valdecilla', Facultad de Medicina, Universidad de Cantabria, Santander</wicri:regionArea><wicri:noRegion>Santander</wicri:noRegion></affiliation></author><author wicri:is="90%"><name sortKey="Rodriguez Valverde, V" sort="Rodriguez Valverde, V" uniqKey="Rodriguez Valverde V" first="V." last="Rodriguez-Valverde">V. Rodriguez-Valverde</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Rheumatology Division, Hospital Universitario "M.Valdecilla', Facultad de Medicina, Universidad de Cantabria, Santander</wicri:regionArea><wicri:noRegion>Santander</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Lupus</title><idno type="ISSN">0961-2033</idno><idno type="eISSN">1477-0962</idno><imprint><publisher>Sage Publications</publisher><pubPlace>Sage CA: Thousand Oaks, CA</pubPlace><date type="published" when="1995-08">1995-08</date><biblScope unit="volume">4</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="259">259</biblScope><biblScope unit="page" to="262">262</biblScope></imprint><idno type="ISSN">0961-2033</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0961-2033</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abramson</term><term>Acute lupus pneumonitis</term><term>Aggregation</term><term>Arthritis</term><term>Arthritis rheum</term><term>Chest radiograph</term><term>Clinical features</term><term>Complement split product</term><term>Complement split products</term><term>Complete resolution</term><term>Corticosteroid</term><term>Corticosteroid therapy</term><term>Disease activity</term><term>Distress syndrome</term><term>Endothelial cells</term><term>Erythematosus</term><term>First patient</term><term>Granulocyte aggregation</term><term>High doses</term><term>Homogeneous pattern</term><term>Hypoxemia</term><term>Hypoxia</term><term>Independent syndrome</term><term>Laboratory data</term><term>Leukocyte aggregation</term><term>Lower extremities</term><term>Lupus</term><term>Malar rash</term><term>Moderate dyspnea</term><term>Multiple blood</term><term>Obvious parenchymal lung disease</term><term>Other hand</term><term>Physical examination</term><term>Pleuritic chest pain</term><term>Pulmonary hemorrhage</term><term>Pulmonary manifestations</term><term>Radiograph</term><term>Respiratory symptoms</term><term>Serum creatinine</term><term>Serum levels</term><term>Several joints</term><term>Syndrome</term><term>Systemic</term><term>Systemic activity</term><term>Systemic lupus erythematosus</term><term>Weight loss</term><term>White woman</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In 1991, Abramson et al reported a new syndrome of acute reversible hypoxemia (ARH) in patients with severe SLE (systemic lupus erythematosus). This syndrome was characterized by an unexplained abnormal value of arterial blood gases (ABG) without obvious parenchymal lung disease, and a good response to high-dose corticosteroid therapy. After we became aware of this entity, four of 16 patients admitted to our unit because of a SLE flare presented respiratory symptoms and abnormal ABG consistent with ARH. In none of our patients were the pulmonary manifestations a prominent clinical feature of the disease. Furthermore, in two of them, treatment with high-dose aspirin and moderate to low doses of corticosteroids was sufficient to improve the pulmonary manifestations, but not to control the systemic activity of the disease. Therefore, we believe that this new pulmonary finding more than a clinically independent syndrome represents an index of disease activity in patients with SLE.</div></front></TEI><affiliations><list><country><li>Espagne</li></country></list><tree><country name="Espagne"><noRegion><name sortKey="Martinez Taboada, V M" sort="Martinez Taboada, V M" uniqKey="Martinez Taboada V" first="V. M." last="Martinez-Taboada">V. M. Martinez-Taboada</name></noRegion><name sortKey="Armona, J" sort="Armona, J" uniqKey="Armona J" first="J." last="Armona">J. Armona</name><name sortKey="Blanco, R" sort="Blanco, R" uniqKey="Blanco R" first="R." last="Blanco">R. Blanco</name><name sortKey="Fernandez Sueiro, J L" sort="Fernandez Sueiro, J L" uniqKey="Fernandez Sueiro J" first="J. L." last="Fernandez-Sueiro">J. L. Fernandez-Sueiro</name><name sortKey="Rodriguez Valverde, V" sort="Rodriguez Valverde, V" uniqKey="Rodriguez Valverde V" first="V." last="Rodriguez-Valverde">V. Rodriguez-Valverde</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B86 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B86 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A35BEBC4904D4EF59DB4F43F3B4B034EE4F5FD8A
|texte= Acute reversible hypoxemia in systemic lupus erythematosus: a new syndrome or an index of disease activity?
}}
| This area was generated with Dilib version V0.6.33. |  |